Effects of Human Activated Protein C Variants in a Rat Model of Arterial Thrombosis
Author Information
Author(s): Karl Malm, Björn Arnljots, Björn Dahlbäck
Primary Institution: Lund University, University Hospital, Malmö, Sweden
Hypothesis
Can human activated protein C variants enhance antithrombotic effects when combined with human protein S in a rat model of arterial thrombosis?
Conclusion
The study found that human activated protein C variants did not produce significant antithrombotic effects in a rat model, even when combined with human protein S.
Supporting Evidence
- Activated protein C is crucial for regulating blood coagulation.
- Previous studies showed antithrombotic effects of activated protein C in other animal models.
- The study found no significant antithrombotic effects of the tested variants in the rat model.
Takeaway
The researchers tested new versions of a blood protein to see if they could help prevent blood clots in rats, but they didn't work as hoped.
Methodology
The study involved a blind randomized trial with 60 rats divided into treatment groups receiving different combinations of activated protein C and protein S.
Limitations
The study's findings may not be applicable across species due to differences in the human and rat hemostatic systems.
Participant Demographics
Sixty male Sprague-Dawley albino rats with a mean body weight of 263 grams.
Statistical Information
P-Value
0.14
Statistical Significance
p=0.14
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website